Immunocore Holdings PLC expected to post a loss of 39 cents a share - Earnings Preview

Immunocore Holdings

02/05/2025 12:11

Immunocore Holdings PLC IMCR.OQ IMCR.O is expected to show a rise in quarterly revenue when it reports  results on May 6 (estimated) for the period ending March 31 2025

The Abingdon Oxfordshire-based  company is expected to report a 24.9% increase in revenue to $88.084 million from $70.5 million a year ago, according to the mean estimate from 13 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Immunocore Holdings PLC is for a loss of 39 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell."

The mean earnings estimate of analysts had fallen by about 0.5% in the last three months. ​

Wall Street's median 12-month price target for Immunocore Holdings PLC is $68.00​, above​ its last closing price of $30.15. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.29
-0.26
-0.47
Missed
-83
Sep. 30 2024
-0.35
-0.35
0.17
Beat
148.4
Jun. 30 2024
-0.55
-0.48
-0.23
Beat
51.7​
Mar. 31 2024
-0.38
-0.36
-0.49
Missed
-35.4
​​Dec. 31 2023
-0.28
-0.28
-0.40
Missed
-47
Sep. 30 2023
-0.35
-0.35
0.05
Beat
113.8​
Jun. 30 2023
-0.40
-0.41
-0.36
Beat
9.7
Mar. 31 2023
-0.45
-0.39
-0.43
Missed
-10.7

This summary was machine generated May 2 at 11:11 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)